Register information Patent

DE file number : 60 2010 037 248.0 (Status: pending/in force, Query started: April 26, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2010 037 248.0
96EP file numberEAKZ14 15 2945.3
97EP publication numberEPN2727918
54Designation/titleTIVerbindungen und Zusammensetzungen als Proteinkinase-Inhibitoren
51IPC main classICM
(ICMV)
C07D 401/14 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
C07D 403/04 (2006.01), A61K 31/506 (2006.01), A61P 35/00 (2006.01)
22DE application dateDATAug 27, 2010
96EP application dateEATAug 27, 2010
43Date of first publicationOTMay 7, 2014
Date of publication of grantPETOct 12, 2016
71/73Applicant/ownerINHArray BioPharma Inc., Boulder, CO, US
72InventorINHuang, Shenlin, San Diego, CA 92130, US; Jin, Xianming, San Ramon, CA 94582, US; Liu, Zuosheng, San Diego, CA 92130, US; Poon, Daniel, Piedmont, CA 94611, US; Tellew, John, La Jolla, CA 92037, US; Wan, Yongqin, San Diego, CA 92121, US; Wang, Xing, San Diego, CA 92127, US; Xie, Yongping, San Diego, CA 92129, US
74RepresentativeVTRLeinweber & Zimmermann Patentanwalts-PartG mbB, 80331 München, DE
Address for service Leinweber & Zimmermann Patentanwalts-PartG mbB, 80331 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
238073 P
Aug 28, 2009
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
313039 P
Mar 11, 2010
LicenceLIZExclusive licence issued
Due dateFT
FG
Aug 31, 2025
Annual fee for the 16th year Patent fees
Patent division in charge 44
21File number of protection certificateZAKZ12 2019 000 023.2
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000002727918
Searchable text: EP000002727918
Original document: EP000002727918B1
Searchable text: EP000002727918B1
43Date of first publicationEVTMay 7, 2014
Date of the first transfer into DPMAregisterEREGTJun 19, 2014
Date of the (most recent) update in DPMAregisterREGTSep 11, 2024
(Show all update days)(Hide all update days)
  • Sep 11, 2024
    • St.36: changed (technical change)
  • Jul 13, 2024; Jul 14, 2023; Jun 28, 2022; Sep 8, 2021; Jul 21, 2021; Sep 3, 2020; Jul 16, 2020; Sep 11, 2019; Aug 14, 2019; Jul 9, 2019; May 16, 2019; Sep 8, 2018; Jun 19, 2018; Oct 26, 2017; Sep 21, 2017; Sep 9, 2017; Sep 7, 2017; Jan 12, 2017; Nov 17, 2016; Oct 15, 2016; Oct 13, 2016; Sep 1, 2016
    • Historical data not available for this/these date(s)
  • Jun 19, 2014
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication May 7, 2014  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Jun 18, 2014 Jun 18, 2014 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Oct 12, 2016  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Nov 24, 2016 Nov 24, 2016 Details anzeigen
5 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Jul 13, 2017 Oct 26, 2017 Details anzeigen
6 Licence Exclusive licence recorded Jun 6, 2018  Details anzeigen
7 New applicant/owner details New applicant/owner details Jul 8, 2019 Aug 14, 2019 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTMay 7, 2014
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTJun 18, 2014
Issue numberHN25
YearPJ2014
Publication dateVTJun 18, 2014
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTOct 12, 2016
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTNov 24, 2016
Issue numberHN47
YearPJ2016
Publication dateVTNov 24, 2016
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTJul 13, 2017
Issue numberHN43
YearPJ2017
Publication dateVTOct 26, 2017
Type of publicationPARTBibliographic data
PartHTPart 3
View procedures Licence (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTLicence
Legal/procedural statusVSTExclusive licence recorded
Date of legal/procedural statusVSTTJun 6, 2018
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJul 8, 2019
Issue numberHN33
YearPJ2019
Publication dateVTAug 14, 2019
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHArray BioPharma Inc., Boulder, CO, US
71/73Previous applicant/ownerINHFArray Biopharma Inc., Boulder, Col., US